Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 80

1.

Drug Class Review on Hormone Therapy for Postmenopausal Women or Women in the Menopausal Transition Stage: Final Report Update # 3 [Internet].

Nelson HD, Nygren P, Freeman M, Chan BKS.

Portland, (OR): Oregon Health & Science University; 2007 Oct.

PMID:
20496442
[PubMed]
Books & Documents
2.

Menopausal hot flushes and night sweats: where are we now?

Archer DF, Sturdee DW, Baber R, de Villiers TJ, Pines A, Freedman RR, Gompel A, Hickey M, Hunter MS, Lobo RA, Lumsden MA, MacLennan AH, Maki P, Palacios S, Shah D, Villaseca P, Warren M.

Climacteric. 2011 Oct;14(5):515-28. doi: 10.3109/13697137.2011.608596. Epub 2011 Aug 18. Review.

PMID:
21848495
[PubMed - indexed for MEDLINE]
3.

Raloxifene effects on vasomotor and other climacteric symptoms in postmenopausal women.

Glusman JE, Huster WJ, Paul S.

Prim Care Update Ob Gyns. 1998 Jul 1;5(4):166.

PMID:
10838311
[PubMed - as supplied by publisher]
4.

Prognostic features of menopausal and postmenopausal applicants for life insurance.

Schiefeling M.

J Insur Med. 1996;28(1):27-34. Review.

PMID:
10172866
[PubMed - indexed for MEDLINE]
5.

Estrogen deficiency symptom management in breast cancer survivors in the changing context of menopausal hormone therapy.

Chlebowski RT, Kim JA, Col NF.

Semin Oncol. 2003 Dec;30(6):776-88. Review.

PMID:
14663778
[PubMed - indexed for MEDLINE]
6.

Menopausal hormone therapy.

Bhavnani BR, Strickler RC.

J Obstet Gynaecol Can. 2005 Feb;27(2):137-62. Review.

PMID:
15937590
[PubMed - indexed for MEDLINE]
7.

Estrogen replacement therapy: indications and complications.

Judd HL, Meldrum DR, Deftos LJ, Henderson BE.

Ann Intern Med. 1983 Feb;98(2):195-205.

PMID:
6824255
[PubMed - indexed for MEDLINE]
8.

Hormone replacement therapy: I. A pharmacoeconomic appraisal of its therapeutic use in menopausal symptoms and urogenital estrogen deficiency.

Whittington R, Faulds D.

Pharmacoeconomics. 1994 May;5(5):419-45. Review. Erratum in: Pharmacoeconomics 1995 Sep;8(3):244.

PMID:
10147233
[PubMed - indexed for MEDLINE]
9.

Standard and low-dose hormone therapy for postmenopausal women--focus on the breast.

Wang PH, Horng HC, Cheng MH, Chao HT, Chao KC.

Taiwan J Obstet Gynecol. 2007 Jun;46(2):127-34. Review.

PMID:
17638620
[PubMed - indexed for MEDLINE]
10.

The physiology, medical management and oral implications of menopause.

Friedlander AH.

J Am Dent Assoc. 2002 Jan;133(1):73-81. Review.

PMID:
11811747
[PubMed - indexed for MEDLINE]
11.

Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society.

North American Menopause Society.

Menopause. 2004 Jan-Feb;11(1):11-33.

PMID:
14716179
[PubMed - indexed for MEDLINE]
12.

Bazedoxifene/conjugated estrogens for menopausal symptom treatment and osteoporosis prevention.

Pinkerton JV, Pickar JH, Racketa J, Mirkin S.

Climacteric. 2012 Oct;15(5):411-8. doi: 10.3109/13697137.2012.696289. Epub 2012 Aug 1. Review.

PMID:
22853444
[PubMed - indexed for MEDLINE]
13.

Tissue-selective agents: selective estrogen receptor modulators and the tissue-selective estrogen complex.

Pickar JH, Mirkin S.

Menopause Int. 2010 Sep;16(3):121-8. doi: 10.1258/mi.2010.010033. Review.

PMID:
20956688
[PubMed - indexed for MEDLINE]
14.

Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review.

Nelson HD.

JAMA. 2004 Apr 7;291(13):1610-20. Review.

PMID:
15069049
[PubMed - indexed for MEDLINE]
15.

Vasomotor flushes in menopausal women.

Bachmann GA.

Am J Obstet Gynecol. 1999 Mar;180(3 Pt 2):S312-6. Review.

PMID:
10076170
[PubMed - indexed for MEDLINE]
16.

Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial.

Hlatky MA, Boothroyd D, Vittinghoff E, Sharp P, Whooley MA; Heart and Estrogen/Progestin Replacement Study (HERS) Research Group.

JAMA. 2002 Feb 6;287(5):591-7.

PMID:
11829697
[PubMed - indexed for MEDLINE]
17.

MF-101, an estrogen receptor beta agonist for the treatment of vasomotor symptoms in peri- and postmenopausal women.

Stovall DW, Pinkerton JV.

Curr Opin Investig Drugs. 2009 Apr;10(4):365-71. Review.

PMID:
19337958
[PubMed - indexed for MEDLINE]
18.
19.

The adverse effects of hormonal therapy.

Bush TL.

Cardiol Clin. 1986 Feb;4(1):145-52. Review.

PMID:
3518931
[PubMed - indexed for MEDLINE]
20.

Estrogen use and postmenopausal women: a basis for informed decisions. NIH Consensus Development.

Gastel B, Cornoni-Huntley J, Brody JA.

J Fam Pract. 1980 Nov;11(6):851-60. Review.

PMID:
7005387
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk